AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04
International Urology Cancer Summit and OncoDaily Announce Strategic Partnership
Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy
AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC
Vivek Subbiah: Rethinking the Unified Cancer of Unknown Primary Concept
10 Must-Read Posts In GU Oncology This Week
Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research
DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC
The 2026 Research Summit, organized by the OSUCCC – James Center for Cancer Engineering – Curing Cancer Through Research in Engineering and Sciences (CCE-CURES), will take place on September 28, 2026, from 7:30 a.m. to 5:00 p.m. in Columbus, Ohio. The event brings together researchers working at the intersection of cancer research, engineering, physical sciences, […]
